About us
Our Story
Leadership
Board of Directors
Scientific Advisory Board
Our Products
Sibnayal®
Other Products
R&D
Disease Focus Area
Distal Renal Tubular Acidosis (dRTA)
Cystinuria
Investors
Investor Relations
Management Team
Press Releases
Events & Presentations
Analyst Coverage
Stock Information
Financial Information
Investors FAQs
Contact Us
EN
FR
Advicenne France
About us
Our Story
Leadership
Board of Directors
Scientific Advisory Board
Our Products
Sibnayal®
Other Products
R&D
Disease Focus Area
Distal Renal Tubular Acidosis (dRTA)
Cystinuria
Investors
Investor Relations
Management Team
Press Releases
Events & Presentations
Analyst Coverage
Stock Information
Financial Information
Investors FAQs
Contact Us
EN
FR
Advicenne France
Nous connaître
Qui sommes-nous ?
L’équipe de direction
Le conseil d’administration
Le conseil scientifique
Nos produits
Sibnayal®
Autres produits
R&D
Pathologies ciblées
Acidose Tubulaire Rénale distale (ATRd)
Cystinurie
Investisseurs
Relations Investisseurs
Équipe de direction
Communiqués de Presse
Événements & Présentations
Analystes
Action Advicenne
Information Financière
FAQ Investisseurs
Contact
EN
FR
Site France
Advicenne announces its 2024 financial calendar
Dec 28, 2023
Advicenne announces its 2024 financial calendar
Retour aux communiqués de presse
Back to press releases
Ouvrir le document
Open the file